COVID-19-Bivalent mRNA vaccine SWIM516(Stemirna Therapeutics)

新冠二价mRNA疫苗SWIM516（斯微生物）

Report date: 2025/01/07 14:46:55

Base Information

Drug NameCOVID-19-Bivalent mRNA vaccine SWIM516(Stemirna Therapeutics)

Drug Alias Name新冠二价mRNA疫苗SWIM516（Delta和BA.2）SWIM516SWIM-516

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccineVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine +[4]

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesStemirna Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesStemirna Therapeutics

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

Other Information

ATC CodeN/A